Department of Orthopaedics, Guangzhou General Hospital of Guangzhou Military Command, Guangzhou, People's Republic of China.
J Mater Sci Mater Med. 2010 Aug;21(8):2453-62. doi: 10.1007/s10856-010-4101-x. Epub 2010 Jun 5.
In this study, silver-loaded coral hydroxyapatites (SLCHAs) were used as scaffolds for bone tissue engineering. The SLCHAs were prepared by surface adsorption process and ion-exchange reaction between Ca(2+) of coral hydroxyapatite (CHA) and Ag(+) of silver nitrate with different concentrations at room temperature. The properties of the composite SLCHAs were investigated by inductively coupled plasma-atomic emission spectrometry (ICP-AES), scanning electron microscropy (SEM) equipped with backscattered electron detector (BSE), and energy-dispersive X-ray spectrometer (EDS). The SEM images showed that the morphology of the SLCHAs depended on the content of Ag(+), and the silver ions were uniformly distributed on the surface of SLCHAs. The ICP-AES results demonstrated that the silver content of the SLCHAs decreased along with the decrease of the concentration of silver nitrate. The SLCHAs were found effective against Escherichia coli and Staphylococcus aureus by antibacterial test. Mouse embryonic pre-osteoblast cells (MC3T3-E1) were used to test the cytocompatibility of SLCHAs, CHA, and pure coral. Cell morphology and cell proliferation were studied with SEM, laser scanning confocal microscope (LSCM), and MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay after 1, 3, and 5 days of culture. The results indicated the cell morphology and proliferation on the scaffolds of Ag(+) (13.6 microg/ml)/CHA and Ag(+) (1.7 microg/ml)/CHA were better than that on Ag(+) (170 microg/ml)/CHA. In addition, adhesion of MC3T3-E1 on the scaffolds showed that the confluent cells showed fusiform shape and arranged tightly on the scaffolds. All the results showed that the antibacterial SLCHAs would have potential clinical application as the scaffolds for bone tissue engineering.
在这项研究中,载银珊瑚羟基磷灰石(SLCHAs)被用作骨组织工程的支架。SLCHAs 通过表面吸附过程和室温下硝酸银与珊瑚羟基磷灰石(CHA)中 Ca(2+)的离子交换反应制备。通过电感耦合等离子体原子发射光谱法(ICP-AES)、扫描电子显微镜(SEM)和背散射电子探测器(BSE)、能谱仪(EDS)研究了复合材料 SLCHAs 的性质。SEM 图像表明,SLCHAs 的形态取决于 Ag(+)的含量,银离子均匀分布在 SLCHAs 的表面。ICP-AES 结果表明,随着硝酸银浓度的降低,SLCHAs 的银含量降低。抗菌试验表明,SLCHAs 对大肠杆菌和金黄色葡萄球菌有效。用小鼠胚胎前成骨细胞(MC3T3-E1)测试 SLCHAs、CHA 和纯珊瑚的细胞相容性。细胞形态和细胞增殖通过 SEM、激光扫描共聚焦显微镜(LSCM)和 MTT(3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴化物)在培养 1、3 和 5 天后进行研究。结果表明,Ag(+)(13.6μg/ml)/CHA 和 Ag(+)(1.7μg/ml)/CHA 支架上的细胞形态和增殖优于 Ag(+)(170μg/ml)/CHA。此外,MC3T3-E1 在支架上的黏附表明,融合细胞呈梭形,紧密排列在支架上。所有结果表明,具有抗菌作用的 SLCHAs 有望作为骨组织工程的支架在临床上得到应用。